Close | |
![]() |
|
Figure 7: The proposed mechanism of hWJMSCs treatment for acute respiratory distress syndrome. The hWJMSCs have a therapeutic effect by inhibiting the production of NF-κB and proinflammatory cytokines such as TNF-α, IL-18, IL-6, IL-1β and decreasing the expression of caspase-1. |
|